Effect of sepsis therapies on health-related quality of life

doi:10.1186/cc6215

Critical Care
Volume 12
Issue 1

Viewing options:

Abstract
Full text
PDF (40KB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Erickson SE
Martin GS

on PubMed

Erickson SE
Martin GS
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Commentary

Effect of sepsis therapies on health-related quality of life

Sara E Erickson and Greg S Martin

Division of Pulmonary, Allergy and Critical Care, Emory University School of Medicine, Grady Memorial Hospital, 49 Jesse Hill Jr Drive SE, Atlanta, GA 30303, USA

author email corresponding author email

Critical Care 2008, 12:109doi:10.1186/cc6215


Published:	22 January 2008

See related research by Longo et al., http://ccforum.com/content/11/6/r128

Abstract

Sepsis is one of the most common conditions encountered in the intensive care unit and is the 10th leading cause of death overall in the United States. Both long-term survival and health-related quality of life are reduced in survivors of sepsis, yet there is little knowledge of the effect of sepsis-specific interventions on either long-term survival or health-related quality of life. The present article discusses the importance of studying health-related quality of life as it relates to sepsis management strategies, particularly in the context of pharmacologic therapy with recombinant human activated protein C.